Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Ganga Pharmaceuticals IPO and Sylph Education IPO.
Ganga Pharmaceuticals IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Sylph Education IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| Ganga Pharmaceuticals IPO | Sylph Education IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | First Overseas Capital Limited | Corporate Strategic Allianz Ltd |
| Registrar | Kfin Technologies Limited | Purva Sharegistry India Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the Sylph Education IPO is up to ₹4.80 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of Sylph Education IPO is ₹12.00 per share.
| Ganga Pharmaceuticals IPO | Sylph Education IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹15.00 per share | ₹12.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 8000 shares | 10000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 10,24,000 shares | 40,00,000 shares |
| Issue Size Total (Amount) | up to ₹1.54 Cr | up to ₹4.80 Cr |
Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while Sylph Education IPO opens on Feb 10, 2016. The closing date of Ganga Pharmaceuticals IPO and Sylph Education IPO is Feb 09, 2016, and Feb 15, 2016, respectively.
| Ganga Pharmaceuticals IPO | Sylph Education IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2016 | Feb 10, 2016 |
| Issue Close | Feb 09, 2016 | Feb 15, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Ganga Pharmaceuticals IPO P/E ratio is , as compared to Sylph Education IPO P/E ratio of .
| Ganga Pharmaceuticals IPO | Sylph Education IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | 91.05% | |
| Promoter Shareholding (Post-Issue) | 68.09% | |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 1.27%% |
In the Ganga Pharmaceuticals IPO retail investors (RII) are offered while in Sylph Education IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in Sylph Education IPO.
| Ganga Pharmaceuticals IPO | Sylph Education IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 56,000 shares | |
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Ganga Pharmaceuticals IPO subscribed in total, whereas Sylph Education IPO subscribed .
| Ganga Pharmaceuticals IPO | Sylph Education IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
